Venture capitalists back away from "me, too" companies (MassDevice)
Venture capitalists are looking to put their money into med-tech's next disruptive device maker, not the companies that follow on its heels.
Venture capitalists have learned their lesson.
The years spent chasing incremental advances in medical device technology yielded disappointing returns, meaning today's funders are looking to put their money into something truly disruptive, according to panelists at yesterday's Wilson Sonsini Goodrich & Rosati Medical Device 2012 Conference.
Medical device industry stakeholders, including entrepreneurs and industry leaders, gathered in San Francisco's Financial District to discuss the challenges facing med-tech start-ups today. The dearth of funding was a common thread among the day's presentations.
A morning panel of 5 VC managers broke down the harsh truth about the state of med-tech funding and why the model might be changing.
"We've got trouble with a capital 'T' here in River City, in Silicon Valley, in southern California, in Boston and New York," Easton Capital Investment Group managing director John Friedman told a morning audience at the Palace Hotel. "We've...
